Acumen Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
427 Park St., Charlottesville, VA

Insiders trading volume in the past year

Acumen Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sands Capital Ventures Discovery Fund III, L.P. 10%+ Owner $11.9M Jul 6, 2021
Robert D. Hardie 10%+ Owner $2.28M Jul 6, 2021
Paul B. Manning 10%+ Owner $2.28M Jul 6, 2021
Daniel Joseph OConnell Chief Executive Officer, Director $1.06M -$108K -9.22% Jan 21, 2025
Matt Zuga CFO & Chief Business Officer $398K -$81K -16.9% Jan 21, 2025
Eric Siemers Chief Medical Officer $271K -$25.2K -8.5% Jan 21, 2025
Derek Meisner Chief Legal Officer & Corp Sec $256K -$25.9K -9.19% Jan 21, 2025
Russell Barton Chief Operating Officer $219K -$18.9K -7.95% Jan 21, 2025
John A. Stalfort III Director $204K Jun 4, 2025
James J. Doherty President and CDO $115K Jan 6, 2025
Nathan B. Fountain Director $21K Jun 4, 2025
Amy Schacterle Chief Regulatory Officer $16.2K Jan 6, 2025
Laura Stoppel Director $14.1K Jun 4, 2025
Jeffrey L. Ives Director $14.1K Jun 4, 2025
Ra Capital Management, L.P. Director, 10%+ Owner $14.1K Jun 4, 2025
Kimberlee C. Drapkin Director $14.1K Jun 4, 2025
Derrell Porter Director $14.1K Jun 4, 2025
Jeffrey Sevigny Director Jun 15, 2022

Recent Insider Transactions by Companies or Individuals for Acumen Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.